Some scientists surprised Oval Office used to release preliminary antiviral drug details
https://ift.tt/35no7jp 
from CBC | Health News https://ift.tt/2zNvWU5
The top U.S. infectious disease official says concerns over leaks compelled him to reveal data on Gilead Sciences Inc.'s experimental drug remdesivir, the first in a scientifically rigorous clinical trial to show benefit in treating COVID-19.
from CBC | Health News https://ift.tt/2zNvWU5
Comments
Post a Comment